Article Sidebar
Published:
Jan 31, 2022DOI:
10.4314/tjpr.v20i6.2Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
MiR-497-5p promotes osteogenic/odontogenic differentiation of stem cells from the apical papilla by regulation of the TGF-β Smad pathway through Smurf2
Abstract
Purpose: To study the influence of miR-497-5p on osteogenic/odontogenic differentiation (OOD) of SCAP, and the signal route involved.
Methods: Four groups were set up: miR-497-5p overexpression group (OEG), overexpression control OEC), miR-497-5p inhibition group, and inhibition control group. Alkaline phosphatase (ALP) activity was assayed, and calcified nodules measured. Protein expression levels of dentine salivary phosphoprotein (DSPP), collagen type I, ALP, osteoblast-related factors (Runx2, OSX and OPN) were also assayed. The mRNA expression levels of osteogenesis/dentin-related genes were determined.
Results: ALP activity was significantly higher in miR-497-5p overexpression cells than in control, but was reduced, relative to inhibition control group (p < 0.05). The miR-497-5p OEG had significantly more calcified nodules than OEC (p < 0.05). There were markedly up-regulated protein expressions in cells of miR-497-5p OEG than in OCG. Furthermore, protein expressions of Smad2, Smad3 and Smad4 in cells of miR-497-5p OEG were significantly up-regulated, relative to those in OEC, but wer lower in miR-497- 5p inhibitory cells than in inhibitory cells.
Conclusion: MiR-497-5p enhances the OOD of SCAP via a mechanism involving TGF-β Smad pathway and Smurf2. Thus, Mir-497-5p may be used as a target for OOD-related drugs.
